NeuroBlate is a minimally invasive procedure. Minimally invasive procedures are generally well tolerated, have a short recovery time and patients go home with 1-2 stitches.
The NeuroBlate System is intended for ablating intracranial soft tissue, including brain structures. There are no known or reported contraindications. The technology is not appropriate for every lesion type and location. It may be difficult to use the technology on certain large or irregularly shaped lesions. Patients must be able to undergo MRI exposure.
Possible adverse events include, but are not limited to, compromised device function, hematoma, embolic events, edema, bleeding, unintended major tissue damage and permanent neurological deficits. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.
The surgeon places the desired NeuroBlate® Optic™ Laser Probe through the robotically controlled probe driver allowing the surgeon to remotely adjust depth and laser directionality as needed during the ablation. A single pre-ablation 3D scan is obtained. The surgeon describes the intended ablation contours, precisely identifies position of the laser probe in the brain, defines the three thermal imaging planes, and starts the ablation. As the tissue heats up, the NeuroBlate Fusion™ Software displays the thermal damage progress in three orthogonal planes relative to trajectory.
The NeuroBlate® System uniquely features TruTemp™ Technology to mitigate the factors that negatively influence MRI thermometry, providing confidence in the accuracy of the ablation zone prediction and added safety assurance.
If deemed necessary, more than one trajectory can be done with a single laser probe without the expense of opening a new one.
The Monteris Mini-Bolt is placed on-trajectory utilizing the stereotactic frame, frameless mini-frame or navigation system of choice. The patient is then moved to the diagnostic MRI using the AtamA™ Patient Board. Alternatively, an intra-operative MRI can be used.
Since the NeuroBlate® System is compatible with multiple stereotactic platforms, the surgeon can leverage their system of choice to plan the surgical approach. Based on the NeuroBlate® Optic™ Laser Probe trajectory and intended ablation area, the surgeon chooses either the NeuroBlate SideFire® directional probe or FullFire® diffusing tip.
NOTE: Functional MRI such as DTI tractography and contoured anatomical objects used during planning can be exported to NeuroBlate Fusion™ Software to assist in ablation volume identification or fused to the intra-operative MRI scan to guide ablation boundaries during the intra-operative stage.
The NeuroBlate® System is indicated for use to ablate, necrotize, or coagulate intracranial soft tissue, including brain structures, through interstitial irradiation or thermal therapy.